RGEN

REPLIGEN CORP

RGEN·759916109·US·Common Stock·Healthcare - Medical Instruments & Supplies-13D/G

RGEN (REPLIGEN CORP) is held by 201 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($734.7M), FMR LLC ($453.9M), UNITED CAPITAL FINANCIAL ADVISORS, LLC ($380.8M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 108 funds bought RGEN.

201
Holders
(17 Elite)
$7.5B
Total Value
54% (200)
Consensus
108 buying - 92 selling
13F: Insider & Congress: Updated regularly
RGEN

Smart Money Verdict

View all
Loading verdict
Held by 201 funds
17 elite

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Oct 8, 2026 · Activists Oct 7, 2026 · Congress Nov 21, 2025

ActivistFMR LLCFMR LLC13.0%Oct 7, 2026
InsiderDRDouglass Brian RobbVest 700 shOct 6, 2026
InsiderLOLoeillot OlivierSell $238KOct 5, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
5.4M(-10.2%)$734.7M0.0%+17.13%
0
Increased
3.3M(+15.2%)$453.9M0.0%+24.71%
36
Increased
2.8M(+0.6%)$380.8M2.1%+31.08%
53
Increased
2.4M(+0.6%)$329M0.0%+48.75%
31
Increased
2.3M(+0.3%)$315.6M0.0%+48.81%
31
Increased
2M(+30.7%)$270.8M2.4%+43.56%
67
Increased
1.8M(+1.3%)$245.7M0.0%+47.73%
31
Decreased
1.8M(-64.1%)$239.1M0.0%+11.47%
0
Increased
1.6M(+15.7%)$220.6M0.1%+13.21%
35
Increased
1.6M(+27.9%)$217M1.4%+11.95%
60
Increased
1.6M(+70.3%)$215M0.0%+22.57%
46
Decreased
1.5M(-0.6%)$207.8M0.0%+27.99%
0
Increased
1.4M(+8.5%)$189.3M0.0%+23.50%
33
Increased
1.3M(+82.3%)$176.3M0.4%+30.38%
56
Increased
1.2M(+2.9%)$169.3M1.4%+11.15%
49
Decreased
1.1M(-0.2%)$145M0.0%+57.85%
0
Increased
1M(+26.9%)$138.1M0.8%-11.41%
53
Increased
965,411(+48.2%)$131.7M0.0%+28.88%
41
Increased
949,863(+11.1%)$129.6M0.0%+43.03%
34
Decreased
890,216(-25.4%)$121.5M0.0%+12.20%
0

Showing 1-20 of 213

1 / 11
RGENRGENREPLIGEN CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used